A clinical perspective on the role of chronic inflammation in gastrointestinal cancer

References

• FerlayJShinHRBrayFFormanDMathersCParkinDMEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer2010127122893291721351269
   PubMed Web of Science ®Google Scholar
• CookMBChowWHDevesaSSOesophageal cancer incidence in the United States by race, sex, and histologic type, 1977–2005Br J Cancer2009101585585919672254
   PubMed Web of Science ®Google Scholar
• LiuJWaalkesMPLiver is a target of arsenic carcinogenesisToxicol Sci20081051243218566022
   PubMed Web of Science ®Google Scholar
• PeekRMJrCrabtreeJEHelicobacter infection and gastric neoplasiaJ Pathol2006208223324816362989
   PubMed Web of Science ®Google Scholar
• Varela-ReyMWoodhooAMartinez-ChantarMLMatoJMLuSCAlcohol, DNA methylation, and cancerAlcohol Res2013351253524313162
   PubMed Web of Science ®Google Scholar
• VirchowRAn address on the value of pathological experimentsBr Med J188121075198203
   Google Scholar
• SpitsHCupedoTInnate lymphoid cells: emerging insights in development, lineage relationships, and functionAnnu Rev Immunol20123064767522224763
   PubMed Web of Science ®Google Scholar
• SpitsHArtisDColonnaMInnate lymphoid cells – a proposal for uniform nomenclatureNat Rev Immunol201313214514923348417
   PubMed Web of Science ®Google Scholar
• LejeuneFJRüeggCLiénardDClinical applications of TNF-alpha in cancerCurr Opin Immunol19981055735809794839
   PubMed Web of Science ®Google Scholar
• DongCDiversification of T-helper-cell lineages: finding the family root of IL-17-producing cellsNat Rev Immunol20066432933316557264
   PubMed Web of Science ®Google Scholar
• RomagnaniSLymphokine production by human T cells in disease statesAnnu Rev Immunol1994122272578011282
   PubMed Web of Science ®Google Scholar
• MiossecPIL-17 and Th17 cells in human inflammatory diseasesMicrobes Infect200911562563019371791
   PubMed Web of Science ®Google Scholar
• GallinJISnydermanRFearonDTHaynesBFNathanCInflammation: Basic Principles and Clinical Correlates3rd edPhiladelphiaLippincott Williams & Wilkins1999
   Google Scholar
• KuperHAdamiHOTrichopoulosDInfections as a major preventable cause of human cancerJ Intern Med2000248317118310971784
   PubMed Web of Science ®Google Scholar
• de MartelCFerlayJFranceschiSGlobal burden of cancers attributable to infections in 2008: a review and synthetic analysisLancet Oncol201213660761522575588
   PubMed Web of Science ®Google Scholar
• MaedaHAkaikeTNitric oxide and oxygen radicals in infection, inflammation, and cancerBiochemistry (Mosc)19986378548659721338
   PubMed Web of Science ®Google Scholar
• JaiswalMLaRussoNFBurgartLJGoresGJInflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanismCancer Res200060118419010646872
   PubMed Web of Science ®Google Scholar
• ChangCLMarraGChauhanDPOxidative stress inactivates the human DNA mismatch repair systemAm J Physiol Cell Physiol20022831C148C15412055083
   PubMed Web of Science ®Google Scholar
• FleisherASEstellerMHarpazNMicrosatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1Cancer Res200060174864486810987299
   PubMed Web of Science ®Google Scholar
• KoshijiMToKKHammerSHIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expressionMol Cell200517679380315780936
   PubMed Web of Science ®Google Scholar
• JungYJIsaacsJSLeeSTrepelJNeckersLIL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesisFASEB J200317142115211712958148
   PubMed Web of Science ®Google Scholar
• EndoYMarusawaHKouTActivation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancersGastroenterology20081353889898898. e1e318691581
   PubMed Web of Science ®Google Scholar
• HudsonJDShoaibiMAMaestroRCarneroAHannonGJBeachDHA proinflammatory cytokine inhibits p53 tumor suppressor activityJ Exp Med1999190101375138210562313
   PubMed Web of Science ®Google Scholar
• YamanishiYBoyleDLRosengrenSGreenDRZvaiflerNJFiresteinGSRegional analysis of p53 mutations in rheumatoid arthritis synoviumProc Natl Acad Sci U S A20029915100251003012119414
   PubMed Web of Science ®Google Scholar
• El-OmarEMCarringtonMChowWHInterleukin-1 polymorphisms associated with increased risk of gastric cancerNature2000404677639840210746728
   PubMed Web of Science ®Google Scholar
• FukataMChenAVamadevanASToll-like receptor-4 promotes the development of colitis-associated colorectal tumorsGastroenterology200713361869188118054559
   PubMed Web of Science ®Google Scholar
• YuHPardollDJoveRSTATs in cancer inflammation and immunity: a leading role for STAT3Nat Rev Cancer200991179880919851315
   PubMed Web of Science ®Google Scholar
• BollrathJPhesseTJvon BurstinVAgp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesisCancer Cell20091529110219185844
   PubMed Web of Science ®Google Scholar
• SonnenbergGFFouserLAArtisDBorder patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22Nat Immunol201112538339021502992
   PubMed Web of Science ®Google Scholar
• CastellanoEDownwardJRAS interaction with PI3K: more than just another effector pathwayGenes Cancer20112326127421779497
   PubMedGoogle Scholar
• Pylayeva-GuptaYGrabockaEBar-SagiDRAS oncogenes: weaving a tumorigenic webNat Rev Cancer2011111176177421993244
   PubMed Web of Science ®Google Scholar
• SuppiahAGreenmanJClinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancerWorld J Gastroenterol201319294651467023922463
   PubMed Web of Science ®Google Scholar
• LiangJNagahashiMKimEYSphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancerCancer Cell201323110712023273921
   PubMed Web of Science ®Google Scholar
• FaustmanDDavisMTNF receptor 2 pathway: drug target for autoimmune diseasesNat Rev Drug Discov20109648249320489699
   PubMed Web of Science ®Google Scholar
• IliopoulosDHirschHAStruhlKAn epigenetic switch involving NF-kappaB, Lin28, Let-7 microRNA, and IL6 links inflammation to cell transformationCell2009139469370619878981
   PubMed Web of Science ®Google Scholar
• Ben-NeriahYKarinMInflammation meets cancer, with NF-kappaB as the matchmakerNat Immunol201112871572321772280
   PubMed Web of Science ®Google Scholar
• SchwitallaSFingerleAACammareriPIntestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like propertiesCell20131521–2253823273993
   PubMed Web of Science ®Google Scholar
• GretenFREckmannLGretenTFIKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancerCell2004118328529615294155
   PubMed Web of Science ®Google Scholar
• KimHJHawkeNBaldwinASNF-kappaB and IKK as therapeutic targets in cancerCell Death Differ200613573874716485028
   PubMed Web of Science ®Google Scholar
• HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
   PubMed Web of Science ®Google Scholar
• FerraraNVascular endothelial growth factor: basic science and clinical progressEndocr Rev200425458161115294883
   PubMed Web of Science ®Google Scholar
• MurdochCMuthanaMCoffeltSBLewisCEThe role of myeloid cells in the promotion of tumour angiogenesisNat Rev Cancer20088861863118633355
   PubMed Web of Science ®Google Scholar
• KeaneMPStrieterRMThe role of CXC chemokines in the regulation of angiogenesisChem Immunol1999728610110550932
   PubMedGoogle Scholar
• TorisuHOnoMKiryuHMacrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alphaInt J Cancer200085218218810629075
   PubMed Web of Science ®Google Scholar
• PeinadoHLavotshkinSLydenDThe secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughtsSemin Cancer Biol201121213914621251983
   PubMed Web of Science ®Google Scholar
• QianBZPollardJWMacrophage diversity enhances tumor progression and metastasisCell20101411395120371344
   PubMed Web of Science ®Google Scholar
• Vidal-VanaclochaFFantuzziGMendozaLIL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1Proc Natl Acad Sci U S A200097273473910639148
   PubMed Web of Science ®Google Scholar
• KalluriRWeinbergRAThe basics of epithelial-mesenchymal transitionJ Clin Invest200911961420142819487818
   PubMed Web of Science ®Google Scholar
• WuYZhouBPTNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasionBr J Cancer2010102463964420087353
   PubMed Web of Science ®Google Scholar
• SullivanNJSasserAKAxelAEInterleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cellsOncogene200928332940294719581928
   PubMed Web of Science ®Google Scholar
• WangHWangHSZhouBHEpithelial-mesenchymal transition (EMT) induced by TNF-α requires AKT/GSK-3β-mediated stabilization of snail in colorectal cancerPLoS One201382e5666423431386
   PubMed Web of Science ®Google Scholar
• WuYDengJRychahouPGQiuSEversBMZhouBPStabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasionCancer Cell200915541642819411070
   PubMed Web of Science ®Google Scholar
• FuxeJKarlssonMCTGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammationSemin Cancer Biol2012225–645546122627188
   PubMed Web of Science ®Google Scholar
• ElderDJHaltonDEHagueAParaskevaCInduction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expressionClin Cancer Res1997310167916839815550
   PubMed Web of Science ®Google Scholar
• García-RodríguezLAHuerta-AlvarezCReduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugsEpidemiology2001121889311138826
   PubMed Web of Science ®Google Scholar
• GuptaRADuboisRNColorectal cancer prevention and treatment by inhibition of cyclooxygenase-2Nat Rev Cancer200111112111900248
   PubMed Web of Science ®Google Scholar
• YinMJYamamotoYGaynorRBThe anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-betaNature1998396670677809817203
   PubMed Web of Science ®Google Scholar
• RoelofsHMTe MorscheRHvan HeumenBWNagengastFMPetersWHOver-expression of COX-2 mRNA in colorectal cancerBMC Gastroenterol201414124383454
   PubMed Web of Science ®Google Scholar
• GurpinarEGrizzleWEPiazzaGACOX-independent mechanisms of cancer chemoprevention by anti-inflammatory drugsFront Oncol2013318123875171
   PubMedGoogle Scholar
• GurpinarEGrizzleWEPiazzaGANSAIDs inhibit tumorigenesis, but how?Clin Cancer Res20142051104111324311630
   PubMed Web of Science ®Google Scholar
• QuailDFJoyceJAMicroenvironmental regulation of tumor progression and metastasisNat Med201319111423143724202395
   PubMed Web of Science ®Google Scholar
• SmithHAKangYThe metastasis-promoting roles of tumor-associated immune cellsJ Mol Med (Berl)201391441142923515621
   PubMed Web of Science ®Google Scholar
• LeekRDLandersRJHarrisALLewisCENecrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breastBr J Cancer1999795–699199510070902
   PubMed Web of Science ®Google Scholar
• GabrilovichDIChenHLGirgisKRProduction of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNat Med1996210109611038837607
   PubMed Web of Science ®Google Scholar
• GeissmannFRevyPRegnaultATGF-beta 1 prevents the non-cognate maturation of human dendritic Langerhans cellsJ Immunol199916284567457510201996
   PubMed Web of Science ®Google Scholar
• HuangBLeiZZhaoJCCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancersCancer Lett20072521869217257744
   PubMed Web of Science ®Google Scholar
• GabrilovichDINagarajSMyeloid-derived suppressor cells as regulators of the immune systemNat Rev Immunol20099316217419197294
   PubMed Web of Science ®Google Scholar
• LindauDGielenPKroesenMWesselingPAdemaGJThe immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cellsImmunology2013138210511523216602
   PubMed Web of Science ®Google Scholar
• ZhaiRChenFLiuGInteractions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinomaJ Clin Oncol201028142445245120385987
   PubMed Web of Science ®Google Scholar
• QuanteMBhagatGAbramsJABile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasiaCancer Cell2012211365122264787
   PubMed Web of Science ®Google Scholar
• SarosiGBrownGJaiswalKBone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett’s esophagusDis Esophagus2008211435018197938
   PubMed Web of Science ®Google Scholar
• WangXOuyangHYamamotoYResidual embryonic cells as precursors of a Barrett’s-like metaplasiaCell201114571023103521703447
   PubMed Web of Science ®Google Scholar
• FitzgeraldRCAbdallaSOnwuegbusiBAInflammatory gradient in Barrett’s oesophagus: implications for disease complicationsGut200251331632212171950
   PubMed Web of Science ®Google Scholar
• Van der VeenAHDeesJBlankensteijnJDVan BlankensteinMAdenocarcinoma in Barrett’s oesophagus: an overrated riskGut198930114182920919
   PubMed Web of Science ®Google Scholar
• de JongePJvan BlankensteinMLoomanCWCasparieMKMeijerGAKuipersEJRisk of malignant progression in patients with Barrett’s oesophagus: a Dutch nationwide cohort studyGut20105981030103620639249
   PubMed Web of Science ®Google Scholar
• Hvid-JensenFPedersenLDrewesAMSørensenHTFunch-JensenPIncidence of adenocarcinoma among patients with Barrett’s esophagusN Engl J Med2011365151375138321995385
   PubMed Web of Science ®Google Scholar
• StonerGDGuptaAEtiology and chemoprevention of esophageal squamous cell carcinomaCarcinogenesis200122111737174611698334
   PubMed Web of Science ®Google Scholar
• SunLYuSMeta-analysis: non-steroidal anti-inflammatory drug use and the risk of esophageal squamous cell carcinomaDis Esophagus201124854454921539676
   PubMed Web of Science ®Google Scholar
• ZhangYEpidemiology of esophageal cancerWorld J Gastroenterol201319345598560624039351
   PubMed Web of Science ®Google Scholar
• KimSSRuizVECarrollJDMossSFHelicobacter pylori in the pathogenesis of gastric cancer and gastric lymphomaCancer Lett2011305222823820692762
   PubMed Web of Science ®Google Scholar
• NaginiSCarcinoma of the stomach: a review of epidemiology, pathogenesis, molecular genetics and chemopreventionWorld J Gastrointest Oncol20124715616922844547
   PubMed Web of Science ®Google Scholar
• LeeKEKhoiPNXiaYHelicobacter pylori and interleukin-8 in gastric cancerWorld J Gastroenterol201319458192820224363509
   PubMed Web of Science ®Google Scholar
• HatakeyamaMOncogenic mechanisms of the Helicobacter pylori CagA proteinNat Rev Cancer20044968869415343275
   PubMed Web of Science ®Google Scholar
• XiongHDuWSunTTA positive feedback loop between STAT3 and cyclooxygenase-2 gene may contribute to Helicobacter pylori-associated human gastric tumorigenesisInt J Cancer201413492030204024127267
   PubMed Web of Science ®Google Scholar
• SobalaGMO’ConnorHJDewarEPKingRFAxonATDixonMFBile reflux and intestinal metaplasia in gastric mucosaJ Clin Pathol19934632352408463417
   PubMed Web of Science ®Google Scholar
• NguyenTLKhuranaSSBelloneCJAutoimmune gastritis mediated by CD4+ T cells promotes the development of gastric cancerCancer Res20137372117212623378345
   PubMed Web of Science ®Google Scholar
• OshimaHOshimaMThe role of PGE2-associated inflammatory responses in gastric cancer developmentSemin Immunopathol201335213915023053397
   PubMed Web of Science ®Google Scholar
• OshimaHIshikawaTYoshidaGJTNF-α/TNFR1 signaling promotes gastric tumorigenesis through induction of Noxo1 and Gna14 in tumor cellsOncogene Epub8262013
   Web of Science ®Google Scholar
• KinoshitaHHirataYNakagawaHInterleukin-6 mediates epithelial-stromal interactions and promotes gastric tumorigenesisPLoS One201384e6091423593346
   PubMed Web of Science ®Google Scholar
• KongDPiaoYSYamashitaSInflammation-induced repression of tumor suppressor miR-7 in gastric tumor cellsOncogene201231353949396022139078
   PubMed Web of Science ®Google Scholar
• LutgensMWvan OijenMGvan der HeijdenGJVleggaarFPSiersemaPDOldenburgBDeclining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studiesInflammatory Bowel Diseases201319478979923448792
   PubMed Web of Science ®Google Scholar
• Peyrin-BirouletLLepageCJoosteVGuéantJLFaivreJBouvierAMColorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008)Inflamm Bowel Dis201218122247225122467511
   PubMed Web of Science ®Google Scholar
• HerszenyiLMihellerPTulassayZCarcinogenesis in inflammatory bowel diseaseDig Dis200725326726917827953
   PubMed Web of Science ®Google Scholar
• DysonJKRutterMDColorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?World J Gastroenterol201218293839384822876036
   PubMed Web of Science ®Google Scholar
• RoglerGChronic ulcerative colitis and colorectal cancerCancer Lett2014345223524123941831
   PubMed Web of Science ®Google Scholar
• KhanAACashPE. coli and colon cancer: is mutY a culprit?Cancer Lett2013341212713123933175
   PubMed Web of Science ®Google Scholar
• FüriISiposFGermannTMEpithelial toll-like receptor 9 signaling in colorectal inflammation and cancer: clinico-pathogenic aspectsWorld J Gastroenterol201319264119412623864774
   PubMed Web of Science ®Google Scholar
• MüzesGMolnárBSiposFRegulatory T cells in inflammatory bowel diseases and colorectal cancerWorld J Gastroenterol201218405688569423155308
   PubMed Web of Science ®Google Scholar
• WhitcombDCInflammation and cancer V. Chronic pancreatitis and pancreatic cancerAm J Physiol Gastrointest Liver Physiol20042872G315G31915246966
   PubMed Web of Science ®Google Scholar
• WörmannSMDiakopoulosKNLesinaMAlgülHThe immune network in pancreatic cancer development and progressionOncogene201433232956296723851493
   PubMed Web of Science ®Google Scholar
• HertzerKMDonaldGWHinesOJCXCR2: a target for pancreatic cancer treatment?Expert Opin Ther Targets201317666768023425074
   PubMed Web of Science ®Google Scholar
• KleeffJKusamaTRossiDLDetection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancerInt J Cancer199981465065710225458
   PubMed Web of Science ®Google Scholar
• BarberMDPowellJJLynchSFFearonKCRossJAA polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancerBr J Cancer200083111443144711076651
   PubMed Web of Science ®Google Scholar
• WörmannSMAlgülHRisk factors and therapeutic targets in pancreatic cancerFront Oncol2013328224303367
   PubMedGoogle Scholar
• KolodecikTShugrueCAshatMThrowerECRisk factors for pancreatic cancer: underlying mechanisms and potential targetsFront Physiol2013441524474939
   PubMed Web of Science ®Google Scholar
• FarrowBEversBMInflammation and the development of pancreatic cancerSurg Oncol200210415316912020670
   PubMed Web of Science ®Google Scholar
• RiveraJARallCJGraeme-CookFAnalysis of K-ras oncogene mutations in chronic pancreatitis with ductal hyperplasiaSurgery1997121142499001550
   PubMed Web of Science ®Google Scholar
• HidalgoMPancreatic cancerN Engl J Med2010362171605161720427809
   PubMed Web of Science ®Google Scholar
• AncrileBLimKHCounterCMOncogenic Ras-induced secretion of IL6 is required for tumorigenesisGenes Dev200721141714171917639077
   PubMed Web of Science ®Google Scholar
• BayneLJBeattyGLJhalaNTumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancerCancer Cell201221682283522698406
   PubMed Web of Science ®Google Scholar
• Pylayeva-GuptaYLeeKEHajduCHMillerGBar-SagiDOncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasiaCancer Cell201221683684722698407
   PubMed Web of Science ®Google Scholar
• BeattyGLChioreanEGFishmanMPCD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humansScience201133160241612161621436454
   PubMed Web of Science ®Google Scholar
• LesinaMKurkowskiMULudesKStat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancerCancer Cell201119445646921481788
   PubMed Web of Science ®Google Scholar
• MichaudDSRole of bacterial infections in pancreatic cancerCarcinogenesis201334102193219723843038
   PubMed Web of Science ®Google Scholar
• DavilaJAMorganROShaibYMcGlynnKAEl-SeragHBHepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based studyGastroenterology200412751372138015521006
   PubMed Web of Science ®Google Scholar
• AyubAAshfaqUAHaqueAHBV induced HCC: major risk factors from genetic to molecular levelBiomed Res Int2013201381046123991421
   PubMed Web of Science ®Google Scholar
• BudhuAWangXWThe role of cytokines in hepatocellular carcinomaJ Leukoc Biol20068061197121316946019
   PubMed Web of Science ®Google Scholar
• Kim doYHanKHEpidemiology and surveillance of hepatocellular carcinomaLiver Cancer20121121424159567
   PubMed Web of Science ®Google Scholar
• MatsuzakiKMurataMYoshidaKChronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinomaHepatology2007461485717596875
   PubMed Web of Science ®Google Scholar
• LokASDoes antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?J Gastroenterol Hepatol201126222122721070361
   PubMed Web of Science ®Google Scholar
• AravalliRNCressmanENSteerCJCellular and molecular mechanisms of hepatocellular carcinoma: an updateArch Toxicol201387222724723007558
   PubMed Web of Science ®Google Scholar
• SeveriTvan MalensteinHVerslypeCvan PeltJFTumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targetsActa Pharmacol Sin201031111409142020953207
   PubMed Web of Science ®Google Scholar
• RamakrishnaGRastogiATrehanpatiNSenBKhoslaRSarinSKFrom cirrhosis to hepatocellular carcinoma: new molecular insights on inflammation and cellular senescenceLiver Cancer201323–436738324400224
   PubMed Web of Science ®Google Scholar
• WhiteDLKanwalFEl-SeragHBAssociation between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic reviewClin Gastroenterol Hepatol2012101213421359. e223041539
   PubMed Web of Science ®Google Scholar
• TackeFYoneyamaHFrom NAFLD to NASH to fibrosis to HCC: role of dendritic cell populations in the liverHepatology201358249449623519833
   PubMed Web of Science ®Google Scholar
• LiangYYangZZhongRPrimary biliary cirrhosis and cancer risk: a systematic review and meta-analysisHepatology20125641409141722504852
   PubMed Web of Science ®Google Scholar
• AravalliRNRole of innate immunity in the development of hepatocellular carcinomaWorld J Gastroenterol201319437500751424282342
   PubMed Web of Science ®Google Scholar
• YangJDNakamuraIRobertsLRThe tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targetsSemin Cancer Biol2011211354320946957
   PubMed Web of Science ®Google Scholar
• PinlaorSMaNHirakuYRepeated infection with Opisthorchis viverrini induces accumulation of 8-nitroguanine and 8-oxo-7,8-dihydro-2′-deoxyguanine in the bile duct of hamsters via inducible nitric oxide synthaseCarcinogenesis20042581535154215059927
   PubMed Web of Science ®Google Scholar
• ShinHROhJKMasuyerEEpidemiology of cholangiocarcinoma: an update focusing on risk factorsCancer Sci2010101357958520085587
   PubMed Web of Science ®Google Scholar
• ClaessenMMHVleggaarFPTytgatKMSiersemaPDvan BuurenHRHigh lifetime risk of cancer in primary sclerosing cholangitisJ Hepatol200950115816419012991
   PubMed Web of Science ®Google Scholar
• EhlkenHSchrammCPrimary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnosticsDig Dis201331111812523797133
   PubMed Web of Science ®Google Scholar
• Al-BahraniRAbuetabhYZeitouniNSergiCCholangiocarcinoma: risk factors, environmental influences and oncogenesisAnn Clin Lab Sci201343219521023694797
   PubMed Web of Science ®Google Scholar
• ChangJSTsaiCRChenLTMedical risk factors associated with cholangiocarcinoma in taiwan: a population-based case-control studyPLoS One201387e6998123894567
   PubMed Web of Science ®Google Scholar
• KhanSAThomasHCDavidsonBRTaylor-RobinsonSDCholangiocarcinomaLancet200536694931303131416214602
   PubMed Web of Science ®Google Scholar
• NairSSBommanaAPakalaSBInflammatory response to liver fluke Opisthorchis viverrini depends on host master coregulator MTA1, a marker for parasite-induced cholangiocarcinoma in humansHepatology20115441388139721725997
   PubMed Web of Science ®Google Scholar
• BerthiaumeEPWandsJThe molecular pathogenesis of cholangiocarcinomaSemin Liver Dis200424212713715192786
   PubMed Web of Science ®Google Scholar
• ParkJTadlockLGoresGJPatelTInhibition of interleukin 6- mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell lineHepatology19993051128113310534331
   PubMed Web of Science ®Google Scholar
• IsomotoHKobayashiSWerneburgNWInterleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cellsHepatology20054261329133816317687
   PubMed Web of Science ®Google Scholar
• KumarSKumarSKumarSInfection as a risk factor for gallbladder cancerJ Surg Oncol200693863363916724347
   PubMed Web of Science ®Google Scholar
• WitkowskaMSmolewskiPHelicobacter pylori infection, chronic inflammation, and genomic transformations in gastric MALT lymphomaMediators Inflamm2013201352317023606792
   PubMed Web of Science ®Google Scholar
• LibraMGloghiniAMalaponteGAssociation of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomasJ Hepatol200849217017418538438
   PubMed Web of Science ®Google Scholar
• LecuitMAbachinEMartinAImmunoproliferative small intestinal disease associated with Campylobacter jejuniN Engl J Med2004350323924814724303
   PubMed Web of Science ®Google Scholar
• ThieblemontCBertoniFCopie-BergmanCFerreriAJPonzoniMChronic inflammation and extra-nodal marginal-zone lymphomas of MALT-typeSemin Cancer Biol201424334224333758
   PubMed Web of Science ®Google Scholar
• WangHPZhuYLShaoWRole of Helicobacter pylori virulence factor cytotoxin-associated gene A in gastric mucosa-associated lymphoid tissue lymphomaWorld J Gastroenterol201319458219822624363512
   PubMed Web of Science ®Google Scholar
• ZulloAHassanCCristofariFEffects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphomaClin Gastroenterol Hepatol 2010201082105110
   Web of Science ®Google Scholar
• LichtensteinGRRutgeertsPImportance of mucosal healing in ulcerative colitisInflamm Bowel Dis201016233834619637362
   PubMed Web of Science ®Google Scholar
• NguyenGCGulamhuseinABernsteinCN5-aminosalicylic acid is not protective against colorectal cancer in inflammatory bowel disease: a meta-analysis of non-referral populationsAm J Gastroenterol2012107912981304 quiz 1297, 130522751467
   PubMed Web of Science ®Google Scholar
• SahinIHHassanMMGarrettCRImpact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: current state-of-the scienceCancer Lett2014345224925724021750
   PubMed Web of Science ®Google Scholar
• YaoXHuangJZhongHTargeting interleukin-6 in inflammatory autoimmune diseases and cancersPharmacol Ther2014141212513924076269
   PubMed Web of Science ®Google Scholar
• RudermanEMOverview of safety of non-biologic and biologic DMARDsRheumatology (Oxford)201251Suppl 6vi37vi4323221586
   PubMed Web of Science ®Google Scholar
• Rose-JohnSWaetzigGHSchellerJGrötzingerJSeegertDThe IL-6/sIL-6R complex as a novel target for therapeutic approachesExpert Opin Ther Targets200711561362417465721
   PubMed Web of Science ®Google Scholar
• GalonJCostesASanchez-CaboFType, density, and location of immune cells within human colorectal tumors predict clinical outcomeScience200631357951960196417008531
   PubMed Web of Science ®Google Scholar
• AngellHGalonJFrom the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancerCurr Opin Immunol201325226126723579076
   PubMed Web of Science ®Google Scholar